These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2239001)

  • 21. Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.
    Argüelles MH; Orellana ML; Castello AA; Villegas GA; Masini M; Belizan AL; González Ayala S; Vera OD; Glikmann G
    J Clin Microbiol; 2006 Aug; 44(8):2733-8. PubMed ID: 16891485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays.
    Arista S; Ferraro D; Cascio A; Vizzi E; di Stefano R
    Res Virol; 1995; 146(3):225-32. PubMed ID: 7481095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 24. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).
    Siennicka J; Częścik A; Trzcińska A
    Przegl Epidemiol; 2014; 68(3):417-20, 527-9. PubMed ID: 25394302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of measles in the Cameroons between 1984 and 1986: comparison of the effectiveness of different serological methods in rural regions.
    Njayou M; Aymard M; Quash G
    J Virol Methods; 1991 Jun; 33(1-2):53-60. PubMed ID: 1939512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.
    Loo MK; Sabahi F; Soleimanjdahi H; Kazemnejad A; Roustai MH
    Eur J Epidemiol; 2003; 18(11):1085-9. PubMed ID: 14620944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal Measles Antibodies and Their Influence on All-cause Mortality Following Measles Vaccination: An Alternative to Measure Very Low Maternal Antibody Levels.
    Smits G; Stabell Benn C; Whittle H; van Binnendijk R; Aaby P; van der Klis F
    Clin Infect Dis; 2019 May; 68(10):1758-1760. PubMed ID: 30329030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.
    Oliveira SA; Siqueira MM; Mann GF; Costa AJ; Almeida MT; Stavola MS; Tomasini H; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):355-8. PubMed ID: 9293077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses.
    Cremer NE; Cossen CK; Shell G; Diggs J; Gallo D; Schmidt NJ
    J Clin Microbiol; 1985 Jun; 21(6):869-74. PubMed ID: 2989325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
    Adu FD; Ikusika A; Omotade O
    J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs.
    Dorigo-Zetsma JW; Leverstein-van Hall MA; Vreeswijk J; de Vries JJ; Vossen AC; Ten Hulscher HI; Kerkhof J; Smits GP; Ruijs WL; Koopmans MP; Binnendijk RS
    J Clin Virol; 2015 Aug; 69():214-8. PubMed ID: 26209410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007.
    Fujisaki R; Yamamura M; Abe S; Shimogawara K; Kasahara M; Nishiya H; Makimura M; Makimura K
    J Infect Chemother; 2012 Jun; 18(3):341-6. PubMed ID: 22134852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.